Patents by Inventor Slki PARK

Slki PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CHIMERIC GENOME ENGINEERING MOLECULES AND METHODS
    Publication number: 20220389404
    Abstract: The present disclosure provides compositions and methods for increasing mutation efficiency and homologous recombination rates of site-specific endonucleases. The compositions and methods comprise a chimeric polypeptide comprising a site-specific endonuclease or a domain thereof and a functional moiety. The current inventions relate to functional enhancement of the CRISPR-Cas enzymes. Disclosed herein include possible variants and their intended improvements.
    Type: Application
    Filed: March 1, 2022
    Publication date: December 8, 2022
    Inventors: Jongjin PARK, Ji Young YOON, Sunmee CHOI, Mijin PARK, Slki PARK, Aiden Y. PARK, Jung Hyuk LEE, Junghak LIM, Dong Wook KIM, Sunghwa CHOE
  • Chimeric genome engineering molecules and methods
    Patent number: 11293019
    Abstract: The present disclosure provides compositions and methods for increasing mutation efficiency and homologous recombination rates of site-specific endonucleases. The compositions and methods comprise a chimeric polypeptide comprising a site-specific endonuclease or a domain thereof and a functional moiety. The current inventions relate to functional enhancement of the CRISPR-Cas enzymes. Disclosed herein include possible variants and their intended improvements.
    Type: Grant
    Filed: December 21, 2018
    Date of Patent: April 5, 2022
    Assignees: GFLAS LIFE SCIENCES, INC., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Jongjin Park, Ji Young Yoon, Sunmee Choi, Mijin Park, Slki Park, Aiden Y. Park, Jung Hyuk Lee, Junghak Lim, Dong Wook Kim, Sunghwa Choe
  • CHIMERIC GENOME ENGINEERING MOLECULES AND METHODS
    Publication number: 20210054362
    Abstract: The present disclosure provides compositions and methods for increasing mutation efficiency and homologous recombination rates of site-specific endonucleases. The compositions and methods comprise a chimeric polypeptide comprising a site-specific endonuclease or a domain thereof and a functional moiety. The current inventions relate to functional enhancement of the CRISPR-Cas enzymes. Disclosed herein include possible variants and their intended improvements.
    Type: Application
    Filed: December 21, 2018
    Publication date: February 25, 2021
    Inventors: Jongjin PARK, Ji Young YOON, Sunmee CHOI, Mijin PARK, Slki PARK, Aiden Y. PARK, Jung Hyuk LEE, Junghak LIM, Dong Wook KIM, Sunghwa CHOE
  • Drug Discovery Methods Using Plant Developmental Biology
    Publication number: 20190119750
    Abstract: The present disclosure relates to a method for discovering effective bioactive compounds, based on plant developmental biology, and aims to discover a lead bioactive compound for new drugs by repeating screening based on phenotypes of a plant as a marker on the basis of plant developmental biology. To this end, the present disclosure provides a method for discovering effective bioactive compounds, and includes screening candidates for developing a new drug by using unique phenotypes as a marker shown by a plant when it is grown with a specific material.
    Type: Application
    Filed: October 30, 2018
    Publication date: April 25, 2019
    Inventors: Sunghwa CHOE, Maya Maharjan PUNA, Slki PARK, Richard CHA
  • DRUG DISCOVERY METHODS USING PLANT DEVELOPMENTAL BIOLOGY
    Publication number: 20170218445
    Abstract: The present disclosure relates to a method for discovering effective bioactive compounds, based on plant developmental biology, and aims to discover a lead bioactive compound for new drugs by repeating screening based on phenotypes of a plant as a marker on the basis of plant developmental biology. To this end, the present disclosure provides a method for discovering effective bioactive compounds, and includes screening candidates for developing a new drug by using unique phenotypes as a marker shown by a plant when it is grown with a specific material.
    Type: Application
    Filed: June 17, 2015
    Publication date: August 3, 2017
    Applicant: SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Sunghwa CHOE, Maya Maharjan PUNA, Slki PARK, Richard CHA